Literature DB >> 21618956

Recent advances in acute lymphoblastic leukemia.

Ching-Hon Pui1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21618956

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


× No keyword cloud information.
  9 in total

Review 1.  Emerging technologies in paediatric leukaemia.

Authors:  Amanda Dixon-McIver
Journal:  Transl Pediatr       Date:  2015-04

2.  A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011).

Authors:  Mignon L Loh; Sarah K Tasian; Karen R Rabin; Patrick Brown; Daniel Magoon; Joel M Reid; Xuejun Chen; Charlotte H Ahern; Brenda J Weigel; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2015-05-13       Impact factor: 3.167

Review 3.  Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.

Authors:  Sarah K Tasian; Mignon L Loh; Stephen P Hunger
Journal:  Cancer       Date:  2015-07-20       Impact factor: 6.860

4.  Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation.

Authors:  V Tosello; F Bordin; J Yu; V Agnusdei; S Indraccolo; G Basso; A Amadori; E Piovan
Journal:  Leukemia       Date:  2015-12-09       Impact factor: 11.528

5.  Diabetes-related autoantibodies in children with acute lymphoblastic leukemia.

Authors:  Carla Bizzarri; Rita M Pinto; Dario Pitocco; Elisa Astorri; Marco Cappa; Mohammed Hawa; Germana Giannone; Andrea Palermo; Ernesto Maddaloni; David R G Leslie; Paolo Pozzilli
Journal:  Diabetes Care       Date:  2012-03       Impact factor: 19.112

6.  Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.

Authors:  R Parameswaran; M Yu; M-A Lyu; M Lim; M G Rosenblum; J Groffen; N Heisterkamp
Journal:  Leukemia       Date:  2012-02-29       Impact factor: 11.528

7.  Calcineurin complex isolated from T-cell acute lymphoblastic leukemia (T-ALL) cells identifies new signaling pathways including mTOR/AKT/S6K whose inhibition synergize with calcineurin inhibition to promote T-ALL cell death.

Authors:  Valeria Tosello; Valentina Saccomani; Jiyang Yu; Fulvio Bordin; Alberto Amadori; Erich Piovan
Journal:  Oncotarget       Date:  2016-07-19

8.  WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia.

Authors:  Fulvio Bordin; Erich Piovan; Elena Masiero; Alberto Ambesi-Impiombato; Sonia Minuzzo; Roberta Bertorelle; Valeria Sacchetto; Giorgia Pilotto; Giuseppe Basso; Paola Zanovello; Alberto Amadori; Valeria Tosello
Journal:  Haematologica       Date:  2017-11-23       Impact factor: 9.941

9.  Adenosine Deaminase 1 as a Biomarker for Diagnosis and Monitoring of Patients with Acute Lymphoblastic Leukemia.

Authors:  Mina Ebrahimi-Rad; Shohreh Khatami; Shahla Ansari; Shohreh Jalylfar; Shirin Valadbeigi; Reza Saghiri
Journal:  J Med Biochem       Date:  2018-04-01       Impact factor: 3.402
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.